Beyond Air (XAIR) Expected to Announce Quarterly Earnings on Tuesday

Beyond Air (NASDAQ:XAIR) is anticipated to issue its Q1 2026 quarterly earnings data after the market closes on Tuesday, August 12th. Analysts expect the company to announce earnings of ($0.08) per share and revenue of $1.75 million for the quarter. Beyond Air has set its FY 2026 guidance at EPS and its Q1 2026 guidance at EPS.

Beyond Air (NASDAQ:XAIR) last released its earnings results on Tuesday, June 17th. The company reported ($1.80) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.80) by $1.00. The firm had revenue of $1.15 million for the quarter, compared to the consensus estimate of $1.39 million. Beyond Air had a negative return on equity of 233.96% and a negative net margin of 1,258.46%. On average, analysts expect Beyond Air to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Beyond Air Stock Performance

Shares of XAIR stock opened at $2.85 on Tuesday. The business has a fifty day moving average of $3.59 and a 200 day moving average of $4.88. Beyond Air has a 1 year low of $2.75 and a 1 year high of $13.52. The company has a debt-to-equity ratio of 0.64, a current ratio of 3.20 and a quick ratio of 2.72. The firm has a market capitalization of $13.22 million, a price-to-earnings ratio of -0.18 and a beta of 0.25.

Analyst Ratings Changes

Several research analysts have recently issued reports on the company. D. Boral Capital began coverage on Beyond Air in a research note on Thursday, July 17th. They issued a “buy” rating and a $11.00 price objective for the company. D Boral Capital raised shares of Beyond Air to a “strong-buy” rating in a research report on Thursday, July 17th. Finally, Wall Street Zen upgraded shares of Beyond Air from a “sell” rating to a “hold” rating in a research note on Saturday, July 26th. One investment analyst has rated the stock with a hold rating, three have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, Beyond Air has an average rating of “Buy” and an average price target of $23.67.

About Beyond Air

Beyond Air, Inc operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn.